167 related articles for article (PubMed ID: 30197540)
1. HPV self-sampling in cervical cancer screening: the effect of different invitation strategies in various socioeconomic groups - a randomized controlled trial.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
Clin Epidemiol; 2018; 10():1027-1036. PubMed ID: 30197540
[TBL] [Abstract][Full Text] [Related]
2. Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2018 Mar; 18(1):273. PubMed ID: 29523108
[TBL] [Abstract][Full Text] [Related]
3. Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
Tranberg M; Bech BH; Blaakær J; Jensen JS; Svanholm H; Andersen B
BMC Cancer; 2016 Nov; 16(1):835. PubMed ID: 27809810
[TBL] [Abstract][Full Text] [Related]
4. Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial.
Montealegre JR; Anderson ML; Hilsenbeck SG; Chiao EY; Cantor SB; Parker SL; Daheri M; Bulsara S; Escobar B; Deshmukh AA; Jibaja-Weiss ML; Zare M; Scheurer ME
Trials; 2020 Oct; 21(1):872. PubMed ID: 33087164
[TBL] [Abstract][Full Text] [Related]
5. Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial.
Winer RL; Lin J; Anderson ML; Tiro JA; Green BB; Gao H; Meenan RT; Hansen K; Sparks A; Buist DSM
JAMA; 2023 Nov; 330(20):1971-1981. PubMed ID: 38015219
[TBL] [Abstract][Full Text] [Related]
6. Participation in interventions and recommended follow-up for non-attendees in cervical cancer screening -taking the women's own preferred test method into account-A Swedish randomised controlled trial.
Lilliecreutz C; Karlsson H; Spetz Holm AC
PLoS One; 2020; 15(7):e0235202. PubMed ID: 32614875
[TBL] [Abstract][Full Text] [Related]
7. Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening.
Costa S; Verberckmoes B; Castle PE; Arbyn M
Br J Cancer; 2023 Mar; 128(5):805-813. PubMed ID: 36517552
[TBL] [Abstract][Full Text] [Related]
8. Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia.
Sultana F; English DR; Simpson JA; Brotherton JM; Drennan K; Mullins R; Heley S; Wrede CD; Saville M; Gertig DM
BMC Cancer; 2014 Mar; 14():207. PubMed ID: 24646201
[TBL] [Abstract][Full Text] [Related]
9. A Home-Mailed Versus General Practitioner-Delivered Vaginal Self-Sampling Kit for Cervical Cancer Screening: A Cluster Randomized Controlled Trial with a Cost-Effectiveness Analysis.
Boyard J; Caille A; Brunet-Houdard S; Sengchanh-Vidal S; Giraudeau B; Marret H; Rolland-Lozachmeur G; Rusch E; Gaudy-Graffin C; Haguenoer K
J Womens Health (Larchmt); 2022 Oct; 31(10):1472-1480. PubMed ID: 35834620
[No Abstract] [Full Text] [Related]
10. Acceptability of human papillomavirus (HPV) self-sampling among never- and under-screened Indigenous and other minority women: a randomised three-arm community trial in Aotearoa New Zealand.
Brewer N; Bartholomew K; Grant J; Maxwell A; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Foliaki S; Cunningham C; Douwes J; Potter JD
Lancet Reg Health West Pac; 2021 Nov; 16():100265. PubMed ID: 34590066
[TBL] [Abstract][Full Text] [Related]
11. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
[TBL] [Abstract][Full Text] [Related]
12. Assessing the impact of mailing self-sampling kits for human papillomavirus testing to unscreened non-responder women in Manitoba.
Jalili F; O'Conaill C; Templeton K; Lotocki R; Fischer G; Manning L; Cormier K; Decker K
Curr Oncol; 2019 Jun; 26(3):167-172. PubMed ID: 31285661
[TBL] [Abstract][Full Text] [Related]
13. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France.
Sancho-Garnier H; Tamalet C; Halfon P; Leandri FX; Le Retraite L; Djoufelkit K; Heid P; Davies P; Piana L
Int J Cancer; 2013 Dec; 133(11):2681-7. PubMed ID: 23712523
[TBL] [Abstract][Full Text] [Related]
14. Sociodemographic characteristics associated with cervical cancer screening participation by send-to-all and opt-in HPV self-sampling: Who benefits? Results from a randomized controlled trial among long-term non-attending women in Norway.
Hansen BT; Nygård M; Castle PE; Burger EA; Aasbø G
Int J Cancer; 2024 May; ():. PubMed ID: 38751040
[TBL] [Abstract][Full Text] [Related]
15. Reaching women who do not participate in the regular cervical cancer screening programme by offering self-sampling kits: a systematic review and meta-analysis of randomised trials.
Verdoodt F; Jentschke M; Hillemanns P; Racey CS; Snijders PJ; Arbyn M
Eur J Cancer; 2015 Nov; 51(16):2375-85. PubMed ID: 26296294
[TBL] [Abstract][Full Text] [Related]
16. Increasing participation in cervical screening by targeting long-term nonattenders: Randomized health services study.
Elfström KM; Sundström K; Andersson S; Bzhalava Z; Carlsten Thor A; Gzoul Z; Öhman D; Lamin H; Eklund C; Dillner J; Törnberg S
Int J Cancer; 2019 Dec; 145(11):3033-3039. PubMed ID: 31032904
[TBL] [Abstract][Full Text] [Related]
17. Effect of Mailed Human Papillomavirus Test Kits vs Usual Care Reminders on Cervical Cancer Screening Uptake, Precancer Detection, and Treatment: A Randomized Clinical Trial.
Winer RL; Lin J; Tiro JA; Miglioretti DL; Beatty T; Gao H; Kimbel K; Thayer C; Buist DSM
JAMA Netw Open; 2019 Nov; 2(11):e1914729. PubMed ID: 31693128
[TBL] [Abstract][Full Text] [Related]
18. Offering Self-Sampling Kits for HPV Testing to Reach Women Who Do Not Attend in the Regular Cervical Cancer Screening Program.
Arbyn M; Castle PE
Cancer Epidemiol Biomarkers Prev; 2015 May; 24(5):769-72. PubMed ID: 25713024
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of Artificial Intelligence-Assisted Decision-making to Improve Vulnerable Women's Participation in Cervical Cancer Screening in France: Protocol for a Cluster Randomized Controlled Trial (AppDate-You).
Selmouni F; Guy M; Muwonge R; Nassiri A; Lucas E; Basu P; Sauvaget C
JMIR Res Protoc; 2022 Aug; 11(8):e39288. PubMed ID: 35771872
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus self-sampling versus standard clinician-sampling for cervical cancer screening in sub-Saharan Africa: a systematic review and meta-analysis of randomized controlled trials.
Tesfahunei HA; Ghebreyesus MS; Assefa DG; Zeleke ED; Acam J; Joseph M; Getachew E; Kajogoo VD; Bekele D; Manyazewal T
Infect Agent Cancer; 2021 Jun; 16(1):43. PubMed ID: 34147103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
